These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 8746489)
1. Stress and depressive symptoms prospectively predict immune change among HIV-seropositive men. HIV Neurobehavioral Research Center Group. Patterson TL; Semple SJ; Temoshok LR; Atkinson JH; McCutchan JA; Straits-Tröster K; Chandler JL; Grant I Psychiatry; 1995 Nov; 58(4):299-312. PubMed ID: 8746489 [TBL] [Abstract][Full Text] [Related]
2. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers. Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977 [TBL] [Abstract][Full Text] [Related]
3. Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men. A 2-year follow-up study. Leserman J; Petitto JM; Perkins DO; Folds JD; Golden RN; Evans DL Arch Gen Psychiatry; 1997 Mar; 54(3):279-85. PubMed ID: 9075469 [TBL] [Abstract][Full Text] [Related]
4. Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors. Leserman J; Petitto JM; Gu H; Gaynes BN; Barroso J; Golden RN; Perkins DO; Folds JD; Evans DL Psychol Med; 2002 Aug; 32(6):1059-73. PubMed ID: 12214787 [TBL] [Abstract][Full Text] [Related]
5. Immune activation markers and AIDS prognosis. Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808 [TBL] [Abstract][Full Text] [Related]
6. Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1. Bello G; Velasco-de-Castro CA; Bongertz V; Rodrigues CA; Giacoia-Gripp CB; Pilotto JH; Grinsztejn B; Veloso VG; Morgado MG J Med Virol; 2009 Oct; 81(10):1681-90. PubMed ID: 19697415 [TBL] [Abstract][Full Text] [Related]
7. Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals. Zangerle R; Steinhuber S; Sarcletti M; Dierich MP; Wachter H; Fuchs D; Möst J Int Arch Allergy Immunol; 1998 Jul; 116(3):228-39. PubMed ID: 9693271 [TBL] [Abstract][Full Text] [Related]
8. Association of depression, CD8+ T lymphocytes, and natural killer cell activity: implications for morbidity and mortality in Human immunodeficiency virus disease. Cruess DG; Douglas SD; Petitto JM; Leserman J; Ten Have T; Gettes D; Dubé B; Evans DL Curr Psychiatry Rep; 2003 Dec; 5(6):445-50. PubMed ID: 14609499 [TBL] [Abstract][Full Text] [Related]
9. Conscientiousness predicts disease progression (CD4 number and viral load) in people living with HIV. O'Cleirigh C; Ironson G; Weiss A; Costa PT Health Psychol; 2007 Jul; 26(4):473-80. PubMed ID: 17605567 [TBL] [Abstract][Full Text] [Related]
10. Serologic confirmation of HIV infection. Chronister CL Optom Vis Sci; 1995 May; 72(5):299-301. PubMed ID: 7667004 [TBL] [Abstract][Full Text] [Related]
11. Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users. Rezza G; Titti F; Pezzotti P; Sernicola L; Lo Caputo S; Angarano G; Lazzarin A; Sinicco A; Rossi GB; Verani P J Biol Regul Homeost Agents; 1992; 6(1):15-20. PubMed ID: 1359736 [TBL] [Abstract][Full Text] [Related]
12. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation. Martinez V; Diemert MC; Braibant M; Potard V; Charuel JL; Barin F; Costagliola D; Caumes E; Clauvel JP; Autran B; Musset L; Clin Infect Dis; 2009 Jan; 48(1):123-32. PubMed ID: 19035778 [TBL] [Abstract][Full Text] [Related]
13. Delayed virus-specific CD8+ cytotoxic T lymphocyte activity in an HIV-infected individual with high CD4+ cell counts: correlations with various parameters of disease progression. Dalod M; Fiorentino S; Delamare C; Rouzioux C; Sicard D; Guillet JG; Gomard E AIDS Res Hum Retroviruses; 1996 Apr; 12(6):497-506. PubMed ID: 8679305 [TBL] [Abstract][Full Text] [Related]
14. Reduced immune activation and T cell apoptosis in human immunodeficiency virus type 2 compared with type 1: correlation of T cell apoptosis with beta2 microglobulin concentration and disease evolution. Michel P; Balde AT; Roussilhon C; Aribot G; Sarthou JL; Gougeon ML J Infect Dis; 2000 Jan; 181(1):64-75. PubMed ID: 10608752 [TBL] [Abstract][Full Text] [Related]
16. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Ironson G; O'Cleirigh C; Fletcher MA; Laurenceau JP; Balbin E; Klimas N; Schneiderman N; Solomon G Psychosom Med; 2005; 67(6):1013-21. PubMed ID: 16314608 [TBL] [Abstract][Full Text] [Related]
17. Association of immune complexes and plasma viral load with CD4+ cell depletion, CD8+ DR+ and CD16+ cell counts in HIV+ hemophilia patients. Implications for the immunopathogenesis of HIV-induced CD4+ lymphocyte depletion. Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G Immunol Lett; 2001 Mar; 76(2):69-78. PubMed ID: 11274723 [TBL] [Abstract][Full Text] [Related]
19. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Evans DL; Ten Have TR; Douglas SD; Gettes DR; Morrison M; Chiappini MS; Brinker-Spence P; Job C; Mercer DE; Wang YL; Cruess D; Dube B; Dalen EA; Brown T; Bauer R; Petitto JM Am J Psychiatry; 2002 Oct; 159(10):1752-9. PubMed ID: 12359683 [TBL] [Abstract][Full Text] [Related]
20. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I. AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]